![Paul L. DeAngelis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Paul L. DeAngelis
Sociétés | Poste | Début | Fin |
---|---|---|---|
Heparinex LLC
![]() Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Directeur Technique/Scientifique/R&D | - | - |
Choncept LLC
![]() Choncept LLC Pharmaceuticals: MajorHealth Technology Choncept LLC produces biotechnology products. It develops chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products. The company was founded by Paul L. DeAngelis in 2002 and is headquartered in Oklahoma City, OK. | Directeur Technique/Scientifique/R&D | 01/01/2002 | - |
Fondateur | 31/07/2009 | - |
Historique de carrière de Paul L. DeAngelis
Anciens postes connus de Paul L. DeAngelis
Sociétés | Poste | Début | Fin |
---|---|---|---|
Hyalose LLC
![]() Hyalose LLC Pharmaceuticals: MajorHealth Technology Hyalose LLC operates as a biotechnology company. It focuses on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HC). It offers Select-HA, Select-HA HiLadder, Select-HA MegaLadder, and Select-HA LoLadder. The company was founded by Paul L. DeAngelis and Paul H. Weigel in 2000 and is headquartered in Oklahoma City, OK. | Directeur Technique/Scientifique/R&D | 01/01/2000 | - |
Fondateur | 28/07/2009 | - |
Formation de Paul L. DeAngelis
Harvard University | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Founder | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Heparinex LLC
![]() Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
Hyalose LLC
![]() Hyalose LLC Pharmaceuticals: MajorHealth Technology Hyalose LLC operates as a biotechnology company. It focuses on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HC). It offers Select-HA, Select-HA HiLadder, Select-HA MegaLadder, and Select-HA LoLadder. The company was founded by Paul L. DeAngelis and Paul H. Weigel in 2000 and is headquartered in Oklahoma City, OK. | Health Technology |
Choncept LLC
![]() Choncept LLC Pharmaceuticals: MajorHealth Technology Choncept LLC produces biotechnology products. It develops chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products. The company was founded by Paul L. DeAngelis in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
- Bourse
- Insiders
- Paul L. DeAngelis
- Expérience